Cypress Capital Group
Source: SEC Form 13F · as of Mar 2026Cypress Capital Group holds 16 biotech & pharma companies tracked by BioSniper, totaling $138.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$138.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 46,836 | $43.1M |
| ABBVAbbVie Inc. | 110,435 | $24.0M |
| JNJJOHNSON & JOHNSON | 80,951 | $19.8M |
| PMPhilip Morris International Inc | 57,607 | $9.5M |
| MRKMerck & Co., Inc. | 58,740 | $7.1M |
| GILDGILEAD SCIENCES, INC. | 48,427 | $6.7M |
| ABTABBOTT LABORATORIES | 65,542 | $6.7M |
| AMGNAMGEN INC | 17,693 | $6.2M |
| BMYBRISTOL MYERS SQUIBB CO | 79,197 | $4.8M |
| CORCencora Inc. | 14,884 | $4.7M |
| PFEPFIZER INC | 130,246 | $3.7M |
| NVSNovartis AG | 5,941 | $907K |
| SUNSUNSET ISLAND GROUP | 8,620 | $560K |
| DGXQuest Diagnostics Incorporated | 2,000 | $392K |
| CAHCardinal Health Inc. | 1,385 | $293K |
| MCKMcKesson Corporation | 269 | $233K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.